- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Cyclone Metals
Lancaster Resources
Purpose Bitcoin ETF
Element79 Gold Corp.
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
InMed Pharmaceuticals announced that it has been included in the CSE25 Index.
InMed Pharmaceuticals (CSE:IN; OTCQB:IMLFF) announced that it has been included in the CSE25 Index.
As quoted in the press release:
InMed qualified for the index as one of the twenty-five largest companies in the CSE Composite Index.
About the CSE25 Index
On September 18, 2017, the Canadian Securities Exchange (“CSE”) announced the introduction of a new index comprised of the securities of the largest companies trading on the exchange.
Source: www.newswire.ca
Outlook Reports
Featured Pharmaceutical Investing Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2385.41 | +3.61 | |
Silver | 28.79 | -0.10 | |
Copper | 4.35 | -0.03 | |
Oil | 85.90 | +0.49 | |
Heating Oil | 2.67 | +0.01 | |
Natural Gas | 1.69 | 0.00 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.